Nutex Health Investors: Lead Plaintiff Deadline Approaching for Securities Fraud Lawsuit

Nutex Health Inc. investors may lead a securities fraud lawsuit due to allegedly false and/or misleading statements and/or failure to disclose information. The lawsuit claims that HaloMD, a third-party IDR vendor, engaged in a scheme to defraud insurance companies, resulting in unsustainable revenues. Investors who purchased Nutex securities between August 8, 2024, and August 14, 2025, have until October 21, 2025, to move the court to serve as lead plaintiff.

Nutex Health Inc. (NASDAQ: NUTX) investors are being urged to join a class action lawsuit alleging securities fraud. The lawsuit, filed on August 22, 2025, claims that the company made false and/or misleading statements and failed to disclose material information during the period between August 8, 2024, and August 14, 2025 [2].

The lawsuit, brought by Lowey Dannenberg P.C., alleges that Nutex's third-party independent dispute resolution vendor, HaloMD, engaged in a scheme to defraud insurance companies. This scheme resulted in unsustainable revenues for Nutex, which were improperly calculated as equity rather than liabilities. As a result, Nutex's financial prospects were overstated, leading to a precipitous decline in the company's common stock once the truth emerged [2].

Investors who purchased Nutex securities during the class period and suffered a loss of more than $50,000 are encouraged to contact Lowey Dannenberg P.C. for more information or to participate in the lawsuit [2]. The deadline to move the court to serve as lead plaintiff is October 21, 2025.

Rosen Law Firm, a global investor rights law firm, has also reminded investors about the class action lawsuit and encourages them to select qualified counsel with a proven track record in securities class actions [1]. Rosen Law Firm achieved the largest ever securities class action settlement against a Chinese company in 2017 and has recovered hundreds of millions of dollars for investors [1].

Investors are advised to review the details of the lawsuit and consult with legal counsel before making any decisions. Until a class is certified, investors are not represented by counsel unless they retain one.

References:
[1] https://www.prnewswire.com/news-releases/nutx-investors-have-opportunity-to-lead-nutex-health-inc-securities-fraud-lawsuit-302547860.html
[2] https://www.morningstar.com/news/globe-newswire/9524188/lowey-dannenberg-notifies-nutex-health-inc-nutex-or-the-company-nasdaq-nutx-investors-of-securities-class-action-lawsuit-and-encourages-investors-with-more-than-50000-in-losses-to-contact-the-firm